ORC Expert Advisory Services ORC International

  home    |    find an expert    |    request an expert    |    join our network    |    about us     expert login  
Expert Consulting and Expert Witness Services
  search tips 
Share this page:  Send to LinkedIn Send to Facebook Tweet This Email Print

 Expert  728672

Expert in Human Immunology

Available for your Consulting and Expert Witness Needs

Education Work History Career AccomplishmentsPublicationsConsulting Services Expert Witness Market Research

Summary of Expertise:

Listed with other top experts in: 

Expert trained in transplantation immunology at Cambridge University, UK, and has since pursued an academic career in human cancer immunology and immunotherapy, and in immunogerontology in Tuebingen, Germany. His research interests are currently centered on alterations to immunity, especially T cell-mediated immunity, in ageing and cancer in man and the influence these have on the outcome of vaccination, including cancer vaccine-based therapies. Recent technological advances in polychromatic flow cytometry and mass cytometry (CyTOF) have expanded the overall focus of monitoring programs to include B cells and innate lymphoid and myeloid cells from patients and aged chprts as well. Tese technqiues are currently employed in his laboratory. In the ageing field, he is currently focusing on mechanisms of human immunosenescence and the role of infection with the common herpesvirus Cytomegalovirus on immunity and mortality in the elderly. The impact of polypathogenicity (including multiple infections, cancer, Alzheimer´s, Parkinson´s and autoimmunity) as well as stress (psychological, nutritional) on immune signatures reflecting individual immune status is of particular interest in the clinical context. In the cancer immunotherapy field he has a long track record in tumour antigen and biomarker discovery, and in monitoring patients undergoing experimental immunotherapy. He defined new tumour antigens recognized by T cells in leukemia and in solid tumours. In chronic myeloid leukemia, he was the first to show that bcr/abl sequences could be immunogenic to CD4+ T cells.. At this time, he led an EU-funded project aimed at establishing best-practise protocols for determining the T cell immunogenicity of synthetic peptide tumour antigens in vitro. Later, he used “reverse immunology” to identify MHC class I and II-restricted antigens in tumours, as well as elution and sequencing of peptides bound to MHC molecules on freshly isolated tumour cells. He works actively with clinical departments in his University and elsewhere to monitor patients receiving immunotherapy for cancer including melanoma, prostate, renal and breast and has extensive collaborations internationally. He has thus maintained an active interest both in the immunotherapy targets present on tumour cells as well as the T cells recognizing them, and the monitoring of patients ex vivo regarding their responses to vaccines containing such tumour antigens. His particular special interest as mentioned above is in the alterations of immune responsiveness with age and how this affects immunotherapy.

He is or has been a member of several industry Advisory Boards on Immunosenescence and Vaccination, and of the WHO Initiative for Vaccine Research Advisory Board on the Impact of Ageing on Vaccination. He is Co-Editor-in Chief of the academic journal Cancer Immunology Immunotherapy, is Deputy Editor of Immunity & Ageing and the Journal of Translational Medicine, and is on the Editorial Boards of J. Gerontol, Mech Ageing Dev, Exp Gerontol and Biogerontol. He has authored >150 peer-reviewed original articles from a total of >300 publications, has edited 3 books and co-edited several others. He has coordinated three European Union collaborative programs on immunosenescence and two on cancer vaccine research. He was an EU 5th Framework Program Expert Advisory Panel Member for Ageing and Public Health, 1997, and 7th FP Expert Consultant for the ‘Road map for the future of ageing research in Europe', 2007 as well as the 7th FP “WhyWeAge” 2010 consulting exercise to make recommendations on the priorities for European research on ageing over the next decade.




biological aging


cancer immunology


cancer immunotherapy



Show Secondary and Basic Areas of Expertise

Year   Degree   Subject   Institution   Honors
1982   PhD   Immunology   Cambridge University  
1974   BA   Natural Sciences   Cambridge University   II.1 (Hons)

Work History:
Years   Employer   Department   Title   Responsibilities

1978 to


(Undisclosed University)


Internal Medicine II




He is head of the Tuebingen Ageing and Tumor Immunogy Group in the Second Department of Internal Medicine, Center for Medical Research of the Expert's University Clinical School

1974 to 1978


University of Cambridge




Research Assistant


Research Assistant doing PhD.

Career Accomplishments:


Professional Appointments

Editor-in-Chief, Cancer Immunology Imunotherapy (Editorial Board member, 1998, Editor-in-Chief, 2003-); Deputy Editor, BMC Immunity and Ageing (2004-), Deputy Editor, J Translational Medicine (2008-); Associate Editor,: Mechanisms of Ageing and Development (1996-), Editorial Board Memberships: Experimental Gerontology (1997-), Biogerontology (1999-), J. Gerontol (2013-)

EU Coordinator: 1. Concerted Action on the Molecular Biology of Immunosenescence (EUCAMBIS, BMHI CT94 1209) (1994-1997); 2. Concerted Action on Peptide Sensitization (EUCAPS, BMHI-CT98-3058) (1998-2001); 3. Immunology and Ageing in Europe (ImAginE, QLK6-1999-02031) (2000-2002), Thematic Network; 4. European Searchable Tumour Cell Line Database (ESTDAB, QLRI-CT-2001-01325) (2001-2004), cost-shared project; 5. T-Cells in Ageing (T-CIA, QLK6-2001-02283) (2002-2005), cost-shared project.


Visiting Professor: Nottingham Trent University, UK

Honorary Chair, Manchester University, UK

Publications and Patents Summary

Currently 156 original publications, 73 review articles, 39 book chapters, 4 books edited. His H index is 67 from >15000 citations

Selected Publications and Publishers  
 - NAS  
 - AACR  
 - Elsevier  
 - ASCO  

Government Experience:
Years   Agency   Role  
2013 to 2013   US NIH   Peer reviewer  
2015 to 2015   US NIH   Peer reviewer  

Consulting Services:
Selected Consulting Examples:
  • He consulted at the European Commission Framework 5 Expert Advisory Panel for Ageing and Public Health, 1997.
  • He was a retained Consultant, Unilever Central Research, Sharnbrooke, Bedford (UK), 1999 - 2005 on matters relating to immunosenescence.
  • He was a 7th FP Expert Consultant for the Workshop ‘Road map for the future of ageing in Europe', 2007, for the European Commission.
  • He was a member of the Sanofi-Pasteur-MSD Member of the Advisory Board on Immunosenescence and Vaccination, 2008, 2009, the WHO Initiative for Vaccine Research, Advisory Board member for impact of ageing on vaccination, 2008 and is a member of the Sanofi-Aventis German Influenza Vaccination Advisory Panel, 2009, 2010.
  • He is a member of the current ILSI Task Force Expert Group on Biomarkers of Inflammation.
Click the green button above to contact Expert for a free initial screening call regarding your expert consulting needs.  Expert is available for consulting to corporate, legal and government clients.  Remember, your initial screening call to speak with Expert is free.

Expert Witness:
Click the green button above to contact Expert for a free initial screening call regarding expert testimony, litigation consulting and support, forensic services, or any related expert witness services.  A few litigation needs include product liability, personal injury, economic loss, intellectual property (patent, trademark, trade secret, copyright), and insurance matters.  Remember, your initial screening call to speak with Expert is free.

International Experience:
Country / Region   Summary
Germany   He is a British Expat living and working in Germany for many years.

Language Skills:
Foreign Language   Description
German   English native tongue, German residence.

Market Research:
Collaborations with industry 1) in EU projects (also as coordinator), 2) in bipartite agreements to perform contract research, 3) as a retained consultant, 4) as an ad-hoc consultant.

Click the green button above to contact Expert for a free initial screening call regarding your marketing research, industry research, and company research needs.  For research needs involving multiple experts or secondary research, a Research Director can be assigned to coordinate the work into a custom report for you as a potentially quicker and more cost effective alternative to doing this work yourself or hiring a boutique consultancy.  Remember, your initial screening call to speak with Expert is free.

Additional Skills and Services:

Teaching graduate students, undergraduates, organising international conferences, symposia, workshops (wet and dry), developing immunology courses and practicals. Seminars for early-career researchers on how to publish papers in scientific journals.

Supplier and Vendor Location and Selection

Running an immunology lab for decades with budget responsibility for equipment and consumables purchases

Other Skills and Services

Medical writing, editing, examining, conference organisation and presentations.


Need the right expert?  We can help!

home       find an expert       request an expert       join our network       about us

Intota is now ORC Expert Advisory Services